Evan Lippman, EVP, Business Development: Teva Pharmaceutical Industries TEVA Sell · Filed 05/18

Trade details

Type: Insider sale
Amount: $204,442.68
Shares · price: 5,746 sh · $35.58 a share
Held after: 6,095 sh
Stock: Teva Pharmaceutical Industries TEVA
Person: Evan LippmanEVP, Business Development
Trade date: 26/05/14
Filed: 26/05/18
Days to filing: 4 days

Sold 48.5% of holdings

Share of holding sold: 48.5%

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 04/14~06/13

Evan Lippman's recent trades

Evan LippmanEVP, Business Development
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$680.3K
18,600 sh
$680.3K
Filed 08/17
Traded 08/17
Evan LippmanEVP, Business Development
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$1.3M
35,912 sh
$1.3M
Filed 05/18
Traded 05/14
Evan LippmanEVP, Business Development
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$1.5M
41,658 sh
$1.5M
Filed 05/14
Traded 05/14

Evan Lippman, EVP — sold $204.4K of Teva Pharmaceutical Industries TEVA · 48.5% of holdings · 10b5-1 plan | Whalegun